Logo image of ACR

ACRES COMMERCIAL REALTY CORP (ACR) Stock Fundamental Analysis

NYSE:ACR - New York Stock Exchange, Inc. - US00489Q1022 - REIT - Currency: USD

18.01  -0.06 (-0.33%)

After market: 18.01 0 (0%)

Fundamental Rating

3

Taking everything into account, ACR scores 3 out of 10 in our fundamental rating. ACR was compared to 65 industry peers in the Mortgage Real Estate Investment Trusts (REITs)" industry. ACR has a medium profitability rating, but doesn't score so well on its financial health evaluation. ACR does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year ACR was profitable.
In the past year ACR had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: ACR reported negative net income in multiple years.
Each year in the past 5 years ACR had a positive operating cash flow.
ACR Yearly Net Income VS EBIT VS OCF VS FCFACR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M -200M

1.2 Ratios

ACR has a better Return On Assets (0.48%) than 61.54% of its industry peers.
ACR has a worse Return On Equity (2.08%) than 61.54% of its industry peers.
With a decent Return On Invested Capital value of 0.54%, ACR is doing good in the industry, outperforming 63.08% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for ACR is in line with the industry average of 1.42%.
The 3 year average ROIC (0.54%) for ACR is below the current ROIC(0.54%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 0.48%
ROE 2.08%
ROIC 0.54%
ROA(3y)0.08%
ROA(5y)-2.31%
ROE(3y)0.25%
ROE(5y)-11.49%
ROIC(3y)0.54%
ROIC(5y)N/A
ACR Yearly ROA, ROE, ROICACR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60

1.3 Margins

ACR has a Profit Margin of 4.57%. This is comparable to the rest of the industry: ACR outperforms 43.08% of its industry peers.
ACR's Profit Margin has declined in the last couple of years.
ACR has a Operating Margin of 5.81%. This is in the lower half of the industry: ACR underperforms 61.54% of its industry peers.
ACR's Operating Margin has declined in the last couple of years.
ACR has a better Gross Margin (38.58%) than 81.54% of its industry peers.
In the last couple of years the Gross Margin of ACR has remained more or less at the same level.
Industry RankSector Rank
OM 5.81%
PM (TTM) 4.57%
GM 38.58%
OM growth 3Y-45.63%
OM growth 5Y-26.08%
PM growth 3Y-34.18%
PM growth 5Y-23.69%
GM growth 3Y-1.09%
GM growth 5Y1.39%
ACR Yearly Profit, Operating, Gross MarginsACR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 200

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ACR is destroying value.
Compared to 1 year ago, ACR has less shares outstanding
The number of shares outstanding for ACR has been reduced compared to 5 years ago.
The debt/assets ratio for ACR has been reduced compared to a year ago.
ACR Yearly Shares OutstandingACR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
ACR Yearly Total Debt VS Total AssetsACR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

ACR has an Altman-Z score of -0.44. This is a bad value and indicates that ACR is not financially healthy and even has some risk of bankruptcy.
ACR has a Altman-Z score of -0.44. This is in the lower half of the industry: ACR underperforms 64.62% of its industry peers.
ACR has a Debt/Equity ratio of 2.80. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of ACR (2.80) is better than 72.31% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.8
Debt/FCF N/A
Altman-Z -0.44
ROIC/WACC0.08
WACC6.8%
ACR Yearly LT Debt VS Equity VS FCFACR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

A Current Ratio of 0.36 indicates that ACR may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.36, ACR is in the better half of the industry, outperforming 61.54% of the companies in the same industry.
A Quick Ratio of 0.36 indicates that ACR may have some problems paying its short term obligations.
ACR's Quick ratio of 0.36 is fine compared to the rest of the industry. ACR outperforms 61.54% of its industry peers.
Industry RankSector Rank
Current Ratio 0.36
Quick Ratio 0.36
ACR Yearly Current Assets VS Current LiabilitesACR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

1

3. Growth

3.1 Past

ACR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -81.86%.
Measured over the past years, ACR shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -15.41% on average per year.
ACR shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -13.64%.
ACR shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.60% yearly.
EPS 1Y (TTM)-81.86%
EPS 3Y-14.61%
EPS 5Y-15.41%
EPS Q2Q%-637.5%
Revenue 1Y (TTM)-13.64%
Revenue growth 3Y21.05%
Revenue growth 5Y6.6%
Sales Q2Q%-9.41%

3.2 Future

Based on estimates for the next years, ACR will show a very negative growth in Earnings Per Share. The EPS will decrease by -11.83% on average per year.
ACR is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -9.44% yearly.
EPS Next Y-62.22%
EPS Next 2Y-11.83%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-3.91%
Revenue Next 2Y-9.44%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ACR Yearly Revenue VS EstimatesACR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 100M 200M
ACR Yearly EPS VS EstimatesACR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 2 -2 4 -4

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 48.68, which means the current valuation is very expensive for ACR.
Based on the Price/Earnings ratio, ACR is valued a bit more expensive than 64.62% of the companies in the same industry.
ACR's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 26.31.
Based on the Price/Forward Earnings ratio of 16.67, the valuation of ACR can be described as correct.
Based on the Price/Forward Earnings ratio, ACR is valued a bit more expensive than 66.15% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.13, ACR is valued a bit cheaper.
Industry RankSector Rank
PE 48.68
Fwd PE 16.67
ACR Price Earnings VS Forward Price EarningsACR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

81.54% of the companies in the same industry are more expensive than ACR, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 67.49
ACR Per share dataACR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40

4.3 Compensation for Growth

ACR's earnings are expected to decrease with -11.83% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-11.83%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for ACR!.
Industry RankSector Rank
Dividend Yield N/A

ACRES COMMERCIAL REALTY CORP

NYSE:ACR (6/13/2025, 8:04:00 PM)

After market: 18.01 0 (0%)

18.01

-0.06 (-0.33%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryMortgage Real Estate Investment Trusts (REITs)"
Earnings (Last)04-30 2025-04-30/amc
Earnings (Next)07-29 2025-07-29/amc
Inst Owners36.3%
Inst Owner Change18.42%
Ins Owners3.32%
Ins Owner Change0%
Market Cap133.09M
Analysts76.67
Price Target22.44 (24.6%)
Short Float %0.81%
Short Ratio1.39
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend2.58
Dividend Growth(5Y)-6.08%
DP219.3%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)19.88%
Min EPS beat(2)-39.59%
Max EPS beat(2)79.34%
EPS beat(4)2
Avg EPS beat(4)-4.01%
Min EPS beat(4)-65.56%
Max EPS beat(4)79.34%
EPS beat(8)6
Avg EPS beat(8)12.99%
EPS beat(12)9
Avg EPS beat(12)8.68%
EPS beat(16)10
Avg EPS beat(16)-15.79%
Revenue beat(2)1
Avg Revenue beat(2)0.8%
Min Revenue beat(2)-3.39%
Max Revenue beat(2)4.99%
Revenue beat(4)1
Avg Revenue beat(4)-3.54%
Min Revenue beat(4)-13.77%
Max Revenue beat(4)4.99%
Revenue beat(8)5
Avg Revenue beat(8)7.31%
Revenue beat(12)9
Avg Revenue beat(12)53.21%
Revenue beat(16)13
Avg Revenue beat(16)80.35%
PT rev (1m)0%
PT rev (3m)12.82%
EPS NQ rev (1m)197.16%
EPS NQ rev (3m)64.06%
EPS NY rev (1m)-68.86%
EPS NY rev (3m)-72.19%
Revenue NQ rev (1m)9.78%
Revenue NQ rev (3m)8.41%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.47%
Valuation
Industry RankSector Rank
PE 48.68
Fwd PE 16.67
P/S 0.67
P/FCF N/A
P/OCF 7
P/B 0.3
P/tB 0.31
EV/EBITDA 67.49
EPS(TTM)0.37
EY2.05%
EPS(NY)1.08
Fwd EY6%
FCF(TTM)-3.52
FCFYN/A
OCF(TTM)2.57
OCFY14.28%
SpS27.01
BVpS59.4
TBVpS58.46
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.48%
ROE 2.08%
ROCE 0.69%
ROIC 0.54%
ROICexc 0.56%
ROICexgc 0.57%
OM 5.81%
PM (TTM) 4.57%
GM 38.58%
FCFM N/A
ROA(3y)0.08%
ROA(5y)-2.31%
ROE(3y)0.25%
ROE(5y)-11.49%
ROIC(3y)0.54%
ROIC(5y)N/A
ROICexc(3y)0.56%
ROICexc(5y)N/A
ROICexgc(3y)0.56%
ROICexgc(5y)N/A
ROCE(3y)0.68%
ROCE(5y)N/A
ROICexcg growth 3Y-26.8%
ROICexcg growth 5Y-15.02%
ROICexc growth 3Y-26.89%
ROICexc growth 5Y-15.13%
OM growth 3Y-45.63%
OM growth 5Y-26.08%
PM growth 3Y-34.18%
PM growth 5Y-23.69%
GM growth 3Y-1.09%
GM growth 5Y1.39%
F-Score8
Asset Turnover0.11
Health
Industry RankSector Rank
Debt/Equity 2.8
Debt/FCF N/A
Debt/EBITDA 57.73
Cap/Depr 464.4%
Cap/Sales 22.55%
Interest Coverage 0.1
Cash Conversion 89.24%
Profit Quality N/A
Current Ratio 0.36
Quick Ratio 0.36
Altman-Z -0.44
F-Score8
WACC6.8%
ROIC/WACC0.08
Cap/Depr(3y)765.92%
Cap/Depr(5y)459.64%
Cap/Sales(3y)30.68%
Cap/Sales(5y)18.42%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-81.86%
EPS 3Y-14.61%
EPS 5Y-15.41%
EPS Q2Q%-637.5%
EPS Next Y-62.22%
EPS Next 2Y-11.83%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-13.64%
Revenue growth 3Y21.05%
Revenue growth 5Y6.6%
Sales Q2Q%-9.41%
Revenue Next Year-3.91%
Revenue Next 2Y-9.44%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-43.89%
EBIT growth 3Y-34.19%
EBIT growth 5Y-21.2%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-425%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-58.7%
OCF growth 3Y-22.36%
OCF growth 5Y-15.19%